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Abstract
Background: Over the past few decades, the Japanese Ministry of the Environment has been biomonitoring
dioxins in the general Japanese population and, in response to public concerns, has taken measures to reduce dioxin
exposure. The objectives of this study were to assess the current dioxin dietary intake and corresponding body burden
in the Japanese and compare Japanese dioxin data from 2011 to 2016 and 2002–2010 surveys. We also examined the
relationship between blood dioxins and health parameters/clinical biomarkers.
Methods: From 2011 to 2016, cross-sectional dioxin surveys were conducted on 490 Japanese (242 males and 248
females, aged 49.9 ± 7.6 years) from 15 Japanese prefectures. Blood (n = 490) and food samples (n = 90) were measured
for 29 dioxin congeners including polychlorinated dibenzo-para-dioxins (PCDDs), polychlorinated dibenzofurans
(PCDFs), and coplanar polychlorinated biphenyls (Co-PCBs) using gas chromatography coupled with high-resolution
mass spectrometry. Using the 2006 World Health Organization toxic equivalence factors, the toxic equivalents (TEQs)
were calculated. Clinical biomarkers and anthropometric parameters were also measured and information on lifestyle
behaviours collected. Data imputations were applied to account for blood dioxins below the detection limit.
Results: The median (95% confidence interval or CI) blood levels and dioxin dietary intake was respectively 9.4 (8.8–9.9)
pg TEQ/g lipid and 0.3 (0.2–0.4) pg TEQ/kg body weight/day. The median blood dioxin level in the 2011–2016 survey
was found to have decreased by 41.3% compared to the 2002–2010 surveys. Participants who were older were found
to be more likely to have higher dioxin levels. Blood dioxins were also significantly associated with body mass index,
triglycerides, docosahexaenoic acid, eicosapentaenoic acid, and dihomo-gamma-linoleic acid levels in blood.
Furthermore, associations between blood dioxin and dietary dioxin intake were evident in the unadjusted models.
However, after adjusting for confounders, blood dioxins were not found to be associated with dietary dioxin intake.
Conclusions: Blood dioxin levels declined over the past decade. This study showed that the measures and
actions undertaken in Japan have possibly contributed to these reductions in the body burden of dioxins in
the Japanese population.
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Introduction
Human exposure to persistent organic pollutants (POPs)
such as dioxins has become a public health concern as
these have been linked to serious health conditions such
as cancer [1], diabetes and hypertension [2, 3]. The gen-
eric term 'dioxins' refers to polychlorinated dibenzo-
para-dioxins (PCDDs), polychlorinated dibenzofurans
(PCDFs) and dioxin-like coplanar polychlorinated biphe-
nyls (Co-PCBs), all of which are by-products of waste in-
cineration and chemical manufacturing processes [4].
Because of their environmental persistence and lipophi-
licity, and the capacity to be carried long distances in
the air before being deposited in water and soils, these
environmental pollutants bio-accumulate in food and
human bodies [5–7].
Most human dioxin exposure in Japan is because of
food consumption and especially from the dioxins in fish
and sea food [8]. Mass poisonings in Japan have been
caused by dioxin-contaminated rice oil, which was called
the Yusho oil disease [9], and from 1990 to 1997, ele-
vated levels of dioxins from municipal solid waste incin-
eration plants contaminated the soil surrounding the
incinerator plants [7, 10].
Recognising the public’s concerns with the high level
of dioxin pollution, the Japanese government promul-
gated regulations and implemented preventive mea-
sures to reduce dioxin emissions from flue gases and
sought to prevent the de novo formation of dioxins.
These measures included a dioxins law related to
‘special measures against dioxins’ released in 1999
[11], improvements in incineration facilities, adequate
waste management and recycling, the clean-up of soil
contaminated with dioxins, and the detoxification and
decomposition of dioxins [7, 11, 12], with most of
these nationwide counter-measures being put in place
by 2004. The Ministry of the Environment of Japan
(MOEJ) reported that these regulatory efforts had re-
sulted in a 95% decline in emitted dioxins (341 g TEQ;
toxic equivalent) by 2004 and a further 98% reduction
by 2010 (158–160 g TEQ) [12] compared to 1997 di-
oxin emissions (7680 g TEQ) [13].
To further evaluate the effectiveness of its actions,
the MOEJ has been biomonitoring dioxins in non-oc-
cupationally exposed individuals. The main problem
with dioxins is that they are lipophilic and can easily
enter the food chain and, as they are resistant to deg-
radation, remain in the environment. Because the
public was concerned about the heightened dioxin
levels found in Japan, the biomonitoring of dioxins
and other chemicals was undertaken to evaluate the
exposure and to prevent potentially adverse effects.
From 2002 to 2010, the MOEJ conducted ‘the survey
on the exposure to dioxins and other chemical
compounds (including pesticides and plasticizers) in
humans’ (SEDOCCH) [2, 3, 8, 14–20] nationwide
(SEDOCCH 2002–2010). The latter aimed to clarify
the relationship between the dioxin dietary intake and
corresponding body burden and other POPs in the
Japanese general population. The results revealed that
the dioxin dietary intake and corresponding TEQ di-
oxins in the blood (median = 16 pg TEQ/g lipid) were
associated with adverse health effects such as diabetes
[2]. SEDOCCH 2002–2010 also found that blood and
food dioxins had had an almost twofold decrease be-
tween 2002 and 2010 and provided evidence-based
data for MOEJ and researcher dioxins surveillance
evaluations. Because of the public concern, the di-
oxins biomonitoring project was continued every year
from 2011 to 2016 (SEDOCCH 2011–2016).
The objectives of this study were to assess current
blood dioxin levels and dietary intake of dioxins in Japa-
nese from the 2011–2016 SEDOCCH data. We also
sought to examine the relationship between blood di-
oxins and health parameters/clinical biomarkers. In
addition, data from the dioxins biomonitoring conducted
from 2011 and 2016 (SEDOCCH 2011–2016) were com-
pared to the results in the 2002–2010 SEDOCCH.
Methods
Study population
A dataset sample from the MOEJ cross-sectional 2011
to 2016 SEDOCCH was used. Sampling from 2011 to
2016 primarily focused on the 15 prefectures in which
the dioxin levels had been found to be high (median
blood dioxins ranging from 21.5 to 40.9 pg TEQ/g lipid)
or low (median blood dioxins between 8.3 and 14.1 pg
TEQ/g lipid) in the 2002–2010 SEDOCCH surveys
[16]. The participants were selected from the urban
areas, agricultural/farming areas and fishing villages,
which were defined as in previous reports [2, 3]. Eighty
participants were planned to be recruited each survey
year through invitation by local administrative authority
using public relations magazines/pamphlets. The inclu-
sion criteria were as follows: adult aged ≥ 20, no known
occupational exposure to dioxins, living in the study
area for at least 10 years, rarely absent from the survey
region for work or other reasons, and no medical re-
strictions for providing blood samples. Pregnant
women and people with diseases, such as anaemia,
were excluded because of possible interferences with
the blood sampling or dioxin measurement. After
consent was obtained, the eligible participants were
invited for an interviewer-administered question-
naire, anthropometry evaluations [blood pressure,
height, weight and body mass index (BMI)] and di-
oxin exposure assessments. In each survey year, 15
(18.8%) individuals among the participants were ran-
domly chosen to provide duplicate diet samples.
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Questionnaire
This study used the same health, lifestyle and food fre-
quency questionnaires as used in the 2002–2010
SEDOCCH survey [16, 19, 20]. Briefly, a trained public
health nurse or nutritionist administered the question-
naire face-to-face. The questionnaire had been sent to
participants in advance for completion at home, after
which the participants were invited to the local commu-
nity centres for the interview. The core questionnaire
gathered sociodemographic information, current health
status and personal medical history (including medica-
tion and diseases diagnoses such as cancer, diabetes,
hypertension and hyperlipidaemia, residential history,
occupational history, tobacco use and alcohol consump-
tion). A semi-structured and open-ended question food
frequency questionnaire was also used to collect infor-
mation on food group intake frequency, in which the
frequencies for 41 foods, food groups, menus and bever-
ages during the previous month were recorded. For ex-
ample, fish consumption frequency was reported in
categorical format using the following eight choices: (1)
Not at all, (2) 1–3 times per month, (3) 1–2 times per
week, (4) 3–4 times per week, (5) 5–6 times per week,
(6) once per week, (7) twice per day and (8) 3 times or
greater per day.
Blood and duplicate diet sampling
Blood drawing was performed on the same day as the
interview survey. The blood collection, processing and
analytical procedures were a revised version of those in
the 2002–2010 SEDOCCH, which have been published
elsewhere [18]. Nearly 50 ml (vs. 20 ml in the 2002–2010
SEDOCCH) of fasting venous blood was drawn by a
nurse or a clinical laboratory technician under the super-
vision of a physician using different vacutainer tubes:
Tubes for blood count and chemical analysis contained
ethylenediaminetetraacetic acid disodium salt (EDTA-
2NA); one for blood glucose, insulin and haemoglobin
A1c (HbA1c) carried sodium fluoride, EDTA-2Na and
sodium heparin, and another one for other clinical test
items with coagulants. Collected blood was shipped to a
contract laboratory (IDEA Consultants, Inc., Yaizu,
Shizuoka, Japan).
Duplicate diet samples were primarily collected to es-
timate dioxin intake, and a diet sample collection was
taken from a subset of the participants during the sur-
vey periods. Consecutive 3-day duplicate participants’
meals were collected by nutritionists and were kept in
stainless steel containers, as previously reported by
Arisawa et al. [15].
Analyses of dioxins
The analytical dioxin methods used in this study were in
accordance with the guidelines published by the Ministry
of Health, Labour and Welfare as detailed in previous re-
ports [14, 21, 22]. The blood and diet samples were
weighed and homogenised before measurement. An ali-
quot of the sample was spiked with internal standards and
a solvent extracted, which was then subjected to a
multi-layer silica column and an activated carbon column
chromatography for purification. Then, the PCDDs,
PCDFs and Co-PCBs (non-ortho PCBs and mono-
ortho-PCBs) in the blood and diet samples were quanti-
fied using gas chromatography coupled with a high-reso-
lution mass spectrometer (IDEA Consultants, Inc.). The
dietary dioxin intake in the diet samples was estimated
using the following equation:
Din ¼ Ddioxin Dsizeð Þ=3
BW
where Din, Ddioxin, Dsize and BW respectively de-
noted the dietary dioxin intake, diet dioxin concentra-
tions (3-day duplicate diets) in pg TEQ/g, the diet
sample size (total amount over 3 days) in grams, and the
body weight of each subject in kilograms. Using the
2006 World Health Organization (WHO) toxic equiva-
lence factors (TEFs), the TEQs were calculated [23].
Blood dioxins were normalised for lipids and expressed
as pg TEQ/g lipid, and the diet dioxin intake was
expressed as pg TEQ/kg body weight/day. The detection
limits for blood dioxins (pg/g lipid) were 1, 2, 4 and 10
for PCDDs/PCDFs with four or five chlorine atoms,
PCDDs/PCDFs with six or seven chlorine atoms,
PCDDs/PCDFs with eight chlorine atoms, and Co-PCBs,
respectively.
Analyses of clinical biomarkers
The blood samples were also subjected to haemato-
logical and biochemical assays. Analyses of clinical
biomarkers (Health Sciences Research Institute, Inc.,
Kanagawa, Japan) were conducted for blood glucose,
HbA1c, lipids [triglycerides and high-density lipopro-
tein (HDL) cholesterol] and blood urea nitrogen, thy-
roid hormones [triiodothyronine (T3) and thyroxine
(T4)] and liver function tests [aspartate aminotrans-
ferase (AST); alanine aminotransferase (ALT);
gamma-glutamyl transpeptidase (GGT)]. Measure-
ments of polyunsaturated fatty acids of eicosapenta-
enoic acid (EPA), docosahexaenoic acid (DHA), and
dihomo-gamma-linolenic acid (DGLA) [2] were per-
formed by SRL Inc. (Tokyo, Japan).
Statistical methods
Stata 14 software (StataCorp LP, College Station, TX,
USA) was used for the analyses. All p values pre-
sented were two-tailed, with p < 0.05 being considered
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significant for all statistical tests. The numerical vari-
ables were assessed for normality using the Shapiro-
Wilk test, and the numerical and qualitative variables
were summarised using descriptive statistics. The nu-
merical variables were presented as the mean ± stand-
ard deviation if the distribution was normal, or as a
median and interquartile range if the distribution was
skewed. Categorical variables were presented as fre-
quencies (percentages), and the differences evaluated
using chi-square tests or Fisher’s exact tests. A Stu-
dent’s t test (to compare two groups) or an ANOVA
(to compare more than two groups) were used for
the equal variance assessment when the data were
normally distributed; however, for skewed data distri-
butions, the Mann-Whitney U test (to compare two
groups) or the Kruskal-Wallis test (to compare more
than two groups) was used. Pearson’s correlations and
multiple regression analyses were undertaken to ex-
plore the relationships between the TEQs and health
parameters/clinical biomarkers. If the health parame-
ters/clinical biomarkers correlated with the total TEQ
and showed a p value ≤ 0.2, they were included in the
multiple regression models. The models were also ad-
justed for smoking status and sex. As the PCDD,
PCDF, Co-PCB and total dioxins (concentrations and
TEQs) distributions were skewed to the right, they
were presented as medians [95% confidence intervals
(CI) or range]. To address the skewedness, the natural
logs of dioxin congeners and total TEQ were used for
the simple correlations and the multiple regression
analyses. A value of zero was assigned to the PCDDs,
PCDFs and Co-PCBs concentrations below the detec-
tion limit with the consideration that this could lead
to bias [24]. A simple substitution of the
non-detectable values was applied for comparison
with the 2002–2010 SEDOCCH survey, in which a
simple substitution approach (assignment of ‘zero’ to
the congener concentrations below the detection
limit) had been used [25]. In the 2002–2010 SEDO
CCH survey, imputation of non-detects was not per-
formed. However, in this study, to estimate the Pear-
son’s r coefficient and in the multiple regression
analyses, the PCDDs, PCDFs and Co-PCBs concentra-
tions below the limit of detection (LOD) were treated
as missing data. To account for the missing dioxin
data, multiple imputations by chained equations
(MICE) and predictive mean matching (PMM) were
applied in Stata to impute the missing data [24, 26,
27]. For missing data exceeding 10%, we used the
multiple imputation strategies following the guidelines
suggested by Newman [28]. Sensitivity analyses were
also conducted to compare the results of the different
methods used to handle the congener concentrations
below the detection limit.
Results
Study population and their health outcome variables
Table 1 and Figure 1 give the details of the 490 partici-
pants [242 males (49.4%); mean age 49.9 years with a
range from 24 to 77] included in the 2011–2016
SEDOCCH surveys. A total of 63.5% of participants had
been recruited from prefectures in which the dioxin
levels were found to be high in the 2002–2010
SEDOCCH results. The clinical and biochemical param-
eters differed in the male and female participants, with
the BMI, smoking status, blood glucose, AST, alanine
transferase ALT, GGT and serum triglycerides generally
found to be higher in the males, and the serum HDL
cholesterols higher in females (Table 1 and Additional
file 1: Table S1). Current male smokers were more likely
to have higher number of cigarettes smoked per day
compared to current female smokers (19 versus 10, re-
spectively). Furthermore, never smokers (mean age 49.9
years with a range from 36 to 72) were slightly older (t
test, p = 0.047) compared with current smokers (mean
age 48.5 years with a range from 24 to 63). HbA1c levels
of ≥ 5.6% were found in 29% (142 of 490) of the partici-
pants indicating probably prediabetes or diabetes; how-
ever, only 7.1% self-reported a history of physician-
diagnosed diabetes (Additional file 1: Table S1). The fish
consumption habits were found to be high in partici-
pants from the fishing villages. For example, only 15.7%
(37/235) of the participants from the fishing villages re-
ported that they do not consume fish at all [versus
37.5% (21/56) in urban areas and 26.6% (53/199) in
farming villages].
Blood dioxins
The detection frequencies and selected percentiles (95%
CI) for the blood dioxin congeners, expressed in pg/g
lipid, and the total TEQ are listed in Table 2. Respect-
ively, the median TEQ for the PCDDs, PCDFs and
Co-PCBs were 3.8, 1.8 and 3.6 pg TEQ/g lipid, and the
median total TEQ in the blood was 9.4 pg TEQ/g lipid
(range, 0.39–59 pg TEQ/glipid). The highest contribu-
tions to the median total TEQ in the blood were found
to come from the PCDDs (41.3%), followed by the
Co-PCBs (39.1%), and the PCDFs (19.6%). When strati-
fying the blood dioxin levels by gender, no statistically
significant differences in median blood dioxin levels
across genders were found (Wilcoxon rank-sum test, p
= 0.712). A comparison of blood dioxins by participants’
region of origin (Fig. 1) found that blood dioxin levels
varied (Kruskal-Wallis test, p < 0.001), with the median
(95% CI) TEQ being highest in participants from Kyu-
shu/Okinawa [11.0 (9.1–12.0)] pg TEQ/g lipid, followed
by those from Chugoku/Shikoku [10.0 (9.3–11.4)] pg
TEQ/g lipid, Tokai/Hokuriku/Kinki [9.3 (7.8–10.0)] pg
TEQ/g lipid and Kanto/Koshinetsu [9.1 (7.5–14.0)] pg
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TEQ/g lipid, and the lowest being found in those from
Hokkaido/Tohoku [7.7 (6.5–9.3)] pg TEQ/g lipid.
Figure 2 shows the blood dioxin trends by survey year.
Overall, a significant decline in blood dioxins was observed
from 2011 to 2016 (Kruskal-Wallis test, p < 0.001). As ex-
pected, we observed that blood dioxins increased with age
(Additional file 2: Figure S1), with median blood dioxins be-
ing significantly lower (Mann-Whitney test, p < 0.001) in
participants aged ≤ 39 years (5.4 pg TEQ/g lipid) than in
those ≥ 40 (9.7 pg TEQ/g lipid). Of the 490 participants,
106 (21.6%) with a mean age of 55 years (range, 41–75)
were found to have blood dioxins ≥ 16 pg TEQ/g lipid (me-
dian TEQ in the 2002–2010 SEDOCCH). The total blood
TEQ medians (95% CI) were higher in areas in which the
blood dioxin levels were reported to be high [10 (9.4–11)
pg TEQ/g lipid] in the 2002–2010 SEDOCCH results
(Wilcoxon rank-sum test, p < 0.001) compared with those
where they were low [7.7 (6.9–8.7) pg TEQ/g lipid].
The median (95% CI) total TEQ in the blood of partic-
ipants living in fishing villages [11.0 (9.7–12.0) pg TEQ/
g lipid] was relatively higher compared to those in urban
[7.4 (5.8–8.8) pg TEQ/g lipid] and agricultural/farming
Table 1 Characteristics of 490 participants in SEDOCCH 2011–2016
Characteristics Male (N = 242) Female (N = 248) All (N = 490) p value†
n (%) or mean (range) n (%) or mean (range) n (%) or mean (range)
Age (years)a 49.4 (24–77) 50.3 (37–72) 49.9 (24–77) 0.135
24–39 25 (5.1) 11 (2.2) 36 (7.3)
40–49 100 (20.4) 111 (22.6) 211 (43.1)
50–59 98 (20.0) 98 (20.0) 196 (40.0)
60–77 19 (3.8) 28 (5.7) 47 (9.6)
BMI (kg/m2)a 24.5 (18.6–36.3) 23.0 (15.5–37.4) 23.7 (15.5–37.4) < 0.001
Underweight (< 18.5) 0 (0.0) 19 (3.8) 19 (3.8)
Normal weight (18.5–24.9) 156 (31.8) 171 (34.9) 327 (66.7)
Overweight (25.0–29.9) 65 (13.2) 46 (9.3) 111 (22.6)
Obese (≥ 30) 21 (4.2) 12 (2.4) 33 (6.7)
Smoker < 0.001
Current 86 (17.6) 16 (3.3) 102 (20.8)
Past 94 (19.2) 23 (4.7) 117 (23.8)
Never 61 (12.4) 207 (42.2) 268 (54.6)
Missing 1 (0.2) 2 (0.4) 3 (0.6)
Number of cigarettes smoked per daya
Current 19 (1–40) 10 (2–20) 17 (1–40) 0.001
Past 20 (1–100) 12 (3–40) 19 (1–100) < 0.001
Not applicable 61 207 268
Missing 3 2 5
Residential area 0.046
Urban 19 (3.8) 37 (7.5) 56 (11.4)
Farming village 104 (21.2) 95 (19.3) 199 (40.6)
Fishing village 119 (24.2) 116 (23.6) 235 (47.9)
Year of survey 0.150
2011 51 (10.4) 35 (7.1) 86 (17.5)
2012 35 (7.1) 49 (10.0) 84 (17.1)
2013 38 (7.7) 45 (9.1) 83 (16.9)
2014 35 (7.1) 46 (9.3) 81 (16.5)
2015 39 (7.9) 37 (7.5) 76 (15.5)
2016 44 (8.9) 36 (7.3) 80 (16.3)
SEDOCCH survey on the exposure to dioxins and other chemical compounds in humans, BMI body mass index
aMean (range)
†p values are comparing male and female participants
Muzembo et al. Environmental Health and Preventive Medicine            (2019) 24:6 Page 5 of 16
areas [8.3 (7.5–9.1) pg TEQ/g lipid]. The median (95%
CI) total TEQ in the blood were significantly lower (Wil-
coxon rank-sum test, p < 0.001) in urban participants
[7.4 (5.8–8.8) pg TEQ/g lipid] than in rural participants
[9.6 (9.1–10.0) pg TEQ/g lipid]. However, no significant
blood dioxin differences were observed between the two
smoking categories, with the median (95% CI) total TEQ
in the blood of non-smokers and smokers being respect-
ively 9.5 (8.8–10.0) pg TEQ/g lipid and 9.2 (7.9–10.0) pg
TEQ/g lipid (Wilcoxon rank-sum test, p = 0.857).
Estimated dioxin dietary intake
Ninety samples were used to estimate the dioxin dietary
intake. Overall, we observed a decline in the dioxin diet-
ary intake per year (Fig. 3). The mean (standard devi-
ation) dietary total TEQ intake was estimated at 0.49
(0.48) pg TEQ/kg body weight/day, and the median
(95% CI) PCDDs/PCDFs and Co-PCBs and total TEQ
intake were respectively, 0.16 (0.12–0.20), 0.16 (0.12–
0.19) and 0.33 (0.25–0.40) pg/kg body weight/day (Add-
itional file 3: Figure S2). The median (95% CI) TEQ diet-
ary intake (pg/kg body weight/day) was found to be the
highest in the fishing areas [0.35 (0.25–0.52)], followed
by the urban areas [0.30 (0.09–1.07)] and the agricul-
tural/farming areas [0.24 (0.19–0.45)]; however, the dif-
ferences were not statistically significant (Kruskal-Wallis
test, p = 0.411). The data also showed that total TEQ in-
take medians (95% CI) were similar in areas in which
the blood dioxin levels were reported to be high [0.30
(0.24–0.38) pg/kg body weight/day] and low [0.39 (0.22–
0.54) pg/kg body weight/day] in the 2002–2010
SEDOCCH results (Wilcoxon rank-sum test, p = 0.843).
Total TEQ intake medians (range) were also similar
(Wilcoxon rank-sum test, p = 0.739) between males [0.33
(0.35–2.30)] and females [0.32 (0.04–2.40)]. However,
these medians tended to increase with age (Fig. 4).
Relationship between blood dioxin TEQ and health
parameters/clinical biomarkers
Table 3 shows the correlations between the blood total
TEQ and health parameters/clinical biomarkers. Positive
correlations were found between age and total TEQ in
the blood, and there were also significant positive corre-
lations between total TEQ in the blood and the esti-
mated dietary TEQ intake, the BMI, abdominal
circumferences, HbA1c, blood glucose, triglycerides,
AST, ALT, GGT, EPA, and DHA. However, total TEQ in
the blood had significant negative correlations with
DGLA and weak negative correlations with triiodothyr-
onine. Regarding the dietary dioxin intake, the results
obtained without imputations of blood dioxin congeners
showed that the Pearson’s correlation coefficients were
similar to those with imputations. For instance, without
imputations, and using the PMM and MICE, the corre-
lations between total TEQ in the blood and the dietary
dioxin intake had Pearson’s correlation coefficients of
0.371, 0.367 and 0.387, respectively.
The results of the adjusted associations between the
total blood dioxin TEQ and health parameters/clinical
biomarkers are shown in Table 4. Consistent positive
Fig. 1 Map of Japan showing the origins of the 490 participants [N (%)] and their median blood dioxin total TEQ (range) in pg TEQ/g lipid. The
geographic patterns of total TEQ presented in each region do not refer to region-level blood dioxin estimates. Instead, this geographic
distribution represents the participants involved in this study. Definition of abbreviations: TEQ, toxic equivalent
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associations were found between the TEQ in the blood
and age, BMIs, DHA and triglycerides while plasma
DGLA was found to have a negative association. Using
multiple imputation methods for the dioxin congeners
concentrations below the LOD, the relationship between
blood dioxins and health parameters/clinical biomarkers
were found to be similar between the models that used
imputed and non-imputed dioxin data. However, the
adjusted R2 from the models that used the simple sub-
stitution dioxin data were different from the models
that used dioxin data imputations, with the PMM (R2



































2011 2012 2013 2014 2015 2016
Year
Fig. 2 (Showing whiskers). Box plot (median, interquartile range and range) of total TEQ in the blood (in pg TEQ/g lipid) by survey year of the
‘survey on the exposure to dioxins and other chemical compounds in humans,’ 2011 to 2016. The median (range) of total TEQ by survey year was
14.0 (0.8–56.0), 9.0 (0.4–40.0), 8.9 (0.4–33.0), 8.3 (1.1–34.0), 8.4 (0.3–49.0) and 9.0 (0.9–29) in 2011, 2012, 2013, 2014, 2015 and 2016, respectively. The
Kruskal-Wallis test (p < 0.001) was used to compare the differences in total TEQ in blood across the survey years. Definition of abbreviations:
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Fig. 3 (Showing whiskers): Estimated dioxin dietary intake by year (n = 15/year). Box plot of total TEQ in food by survey year of the ‘survey on the
exposure to dioxins and other chemical compounds in humans,’ 2011 to 2016 (N = 90)The median (range) of dioxin dietary intake (in pg TEQ/kg
body weight/day) by survey year was 2011, 0.39 (0.03–2.4); 2012, 0.57 (0.07–2.3); 2013, 0.23 (0.04–1.6); 2014, 0.34 (0.08–1.3); 2015, 0.25 (0.13–1.1);
and 2016, 0.33 (0.06–1.6). Kruskal-Wallis test: χ2 = 11.25; d.f. = 5; p = 0.046. TEQ, toxic equivalents.
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evidence compared with the simple substitution method
(R2 = 0.410). In adjusted linear regression models that in-
cluded smoking status, we found no association between
smoking status and the total blood dioxin TEQ using the
simple substitution method (beta = − 0.347; p = 0.420; R2 =
0.410), PMM (beta = 0.073; p = 0.856; R2 = 0.480), and
MICE (beta = − 0.011; p = 0.777; R2 = 0.440). Including
smoking status in the models had no effect on the signifi-
cance of the models (Table 4) and increased slightly the
variance inflation factor (VIF) from 1.33 to 1.42. It was also
found that the VIF was 2.2 for EPA, DHA, DGLA, ALT,
AST and GGT. However, VIF dropped to 1.1 when EPA,
AST and GGT were excluded, indicating that there were
some collinearities between clinical biomarkers [AST and
GGT correlated with ALT (rho = 0.739 and rho = 0.624, re-
spectively) whereas EPA with DHA (rho = 0.778)]. Using
MICE, after multivariable adjustment, we also found as-
sociations between total blood dioxin TEQ and EPA
(beta = 0.270; p < 0.001; R2 = 0.425). In the model re-
stricted to the 90 participants for whom dietary dioxin
intake estimations were available (listwise deletion), we
could not detect an association between total blood di-
oxin TEQ and dietary dioxin intake after multivariable
adjustment (Additional file 1: Table S2).
Discussion
The SEDOCCH, which were designed to assess the
health risks of pollutants such as dioxins and dietary di-
oxins intake in the general Japanese population, were a
series of biomonitoring studies conducted by the MOEJ
on non-occupationally exposed Japanese [18]. This study
evaluated the progress made by the government to
decrease the dioxin dietary intake and corresponding
body burden.
Current dioxin levels in Japanese from the 2011–2016
SEDOCCH data
It was found that the median concentration of blood di-
oxin TEQ in the general adult Japanese population was
9.40 pg TEQ/g lipid and the dietary dioxin intake was
0.33 pg TEQ/kg body weight/day. Blood dioxins (5.4 pg
TEQ/g lipid) in participants aged ≤ 39 years were par-
ticularly striking, suggesting that dioxin exposure inten-
sity and accumulation time were probably limited in this
age group. However, only a small percentage (7.3%) of
the participants aged ≤ 39 years was included in this
study. Higher median blood dioxins were found in par-
ticipants aged ≥ 40 years old, which supported findings
in previous studies on the lipophilicity of dioxins and
their accumulation in adipose tissues over a lifetime
[29]. The national estimates of blood dioxins found in
this study matched international trends and were in line
with a review that reported worldwide decreasing
PCDD/PCDFs TEQ values in samples collected up to
2008 [30], but were lower than the median values re-
ported in Russian women in 2010 [31]. TEQ values or
that of congeners reported in this study might be diffi-
cult to compare between countries/studies because there
is significant heterogeneity in the study designs, analyt-
ical methods, handling values below the LOD and TEF
utilisation. For instance, a study conducted in rural



































24–39 (n = 8) 40–49 (n = 28) 50–59 (n = 41) 60–77 (n = 13)
Age group (year)
Fig. 4 (Showing whiskers): Estimated dioxin dietary intake by age. Box plot of total TEQ in food by age group of the ‘survey on the exposure to
dioxins and other chemical compounds in humans,’ 2011 to 2016 (N = 90). The median (range) of dioxin dietary intake (in pg TEQ/kg body
weight/day) by age group (year) was 24–39, 0.22 (0.08–0.54); 40–49, 0.23 (0.03–2.3); 50–59, 0.38 (0.04–2.4); and 60–77, 0.48 (0.09–1.6). Kruskal-Wallis
test: χ2 = 8.87; d.f. = 3; p = 0.031. TEQ, toxic equivalents.
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g lipid (vs. 9.4 pg TEQ/g lipid in this study) [32]. How-
ever, our study population differed considerably from
the study conducted in Germany. The latter study used
the 2005 WHO TEFs (vs. 2006 WHO TEFs in this
study) with a sample size of 70 (vs. 490 in this study)
and its participants’ age ranged from 4 to 76 years (vs.
24–77 years in this study). The fact that the German’s
study included relatively younger participants might
have contributed to the relatively lower reported total
TEQ value. The PCDD/PCDFs and Co-PCBs values
found in this study are similar to those reported in an-
other recent study conducted in Germany that had
looked at chlorinated dioxins in 42 blood donors [33].
The study in the German blood donors has documented
a PCDD/PCDFs value of 6.2 pg TEQ/g lipid (vs. 5.7 pg
TEQ/g lipid in this study) and Co-PCBs of 4.1 pg TEQ/g
lipid (vs. 3.6 pg TEQ/g lipid) among participants aged 20
to 68 years [33]. Moreover, a study conducted in Ghana
among individuals working at e-waste recycling sites and
controls who were not directly exposed to e-waste recyc-
ling activities reported a PCDD/PCDFs value of 4.6 pg
TEQ/g lipid (vs. 5.7 pg TEQ/g lipid in this study) in con-
trols with a mean age of 24.4 years (vs. 49.4 years in this
study) [34].
In this study, the dietary dioxin exposure was esti-
mated using a duplicate diet analysis from three con-
secutive days [15], from which it was found that none of
the participants exceeded the tolerable daily dioxin in-
take of 4 pg/kg body weight/day stipulated in the ‘Act on
Special Measures against Dioxins’ [11]. The highest diet-
ary dioxins intake was found in participants living in
fishing areas (0.35 pg/kg body weight/day), which sup-
ported previous data that suggested that fish and sea
foods were more vulnerable to dioxin contamination [8,
35]. These findings were also consistent with a report by
Arisawa et al., in which it was found that the highest
dietary dioxin intake was in Japanese from fishing vil-
lages; however, the previously reported value (0.98 pg/kg
Table 3 Pearson’s correlation between log-transformed blood dioxins (in pg TEQ/g lipid) and health outcomes, SEDOCCH 2011–
2016
Variables Total TEQ with ‘zero’ substituted for
dioxin congeners < LOD
Total TEQ with dioxins imputed
using PMM
Total TEQ with dioxins imputed
using MICE
r p value r p value r p value
Age (years) 0.443 < 0.001 0.556 < 0.001 0.501 < 0.001
BMI (kg/m2) 0.194 < 0.001 0.150 < 0.001 0.160 < 0.001
Abdominal circumference (cm) 0.164 0.001 0.142 0.001 0.139 0.001
Number of cigarettes smoked per day* 0.017 0.701 0.064 0.157 0.044 0.330
HbA1c (NGSP value, %)* 0.136 0.006 0.198 < 0.001 0.192 < 0.001
Blood glucose (mg/dL) 0.232 < 0.001 0.272 < 0.001 0.264 < 0.001
Insulin (μU/mL) − 0.009 0.827 − 0.040 0.373 − 0.031 0.482
Triglycerides (mg/dL) 0.202 < 0.001 0.198 < 0.001 0.188 < 0.001
HDL cholesterol (mg/dL) − 0.080 0.074 − 0.088 0.051 − 0.082 0.067
Free T3 (pg/mL) − 0.099 0.028 − 0.098 0.029 − 0.095 0.034
Blood urea nitrogen (mg/dL) 0.093 0.038 0.114 0.011 0.112 0.013
Blood creatinine (mg/dL)c − 0.030 0.497 − 0.046 0.309 − 0.040 0.366
AST (IU/L) 0.169 < 0.001 0.155 < 0.001 0.166 < 0.001
ALT (IU/L) 0.128 0.004 0.100 0.025 0.111 0.013
GGT (IU/L) 0.151 < 0.001 0.117 < 0.009 0.123 0.006
DGLA (μg/mL) − 0.131 0.003 − 0.132 0.003 − 0.145 0.001
AA (μg/mL) − 0.024 0.584 − 0.033 0.456 − 0.038 0.398
EPA (μg/mL) 0.452 < 0.001 0.473 < 0.001 0.463 < 0.001
DHA (μg/mL) 0.440 < 0.001 0.441 < 0.001 0.435 < 0.001
Dietary dioxin intake (pg TEQ/kg/day)* 0.371 < 0.001 0.367 < 0.001 0.387 < 0.001
All variables were log-transformed, except age and the number of cigarettes smoked per day
SEDOCCH survey on the exposure to dioxins and other chemical compounds in humans, PCDDs polychlorinated dibenzo-dioxins, PCDFs polychlorinated
dibenzofurans, Co-PCBs coplanar polychlorinated biphenyls, TEQ toxicity equivalent, BMI body mass index, HbA1c haemoglobin A1c, NGSP National
Glycohemoglobin Standardisation Programme, HDL high-density lipoprotein, T3 triiodothyronine, AST aspartate aminotransferase, ALT alanine aminotransferase,
GGT gamma-glutamyl transpeptidase, DGLA dihomo-gamma-linolenic acid, AA arachidonic acid, EPA eicosapentaenoic acid, DHA docosahexaenoic acid, PMM
predictive mean matching, MICE multiple chained equations
*N = 490, except for HbA1c (n = 404), number of cigarettes smoked per day (n = 485) and dietary dioxin intake (n = 90). Missing data of covariates were
not imputed
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body weight/day) was higher than that found in the
current study [15]. The estimated mean dietary dioxin
intake (0.49 pg TEQ/kg body weight/day) found in this
study was approximately three times lower that that re-
ported in a French study from 2015, which reported a
mean of 1.3 pg TEQ/kg body weight/day [36]. However,
in the latter study, the data were collected between 1993
and 2008 when dioxin levels in the environment were
probably higher than now.
Comparison of the 2002–2010 and 2011–2016 SEDOCCH
data
In reference to age, it was expected that the dioxin levels
would be higher in participants in this study (mean age
= 49.9 years) than those in the 2002–2010 SEDOCCH
(mean age = 44.5 years; N = 2264) [20]; however, this was
not found. A comparison of the median blood dioxin
levels reported in this study found that the blood dioxin
TEQ were 41.3% lower than that those reported in the
2002–2010 SEDOCCH, which had reported a median of
16 pg TEQ/g lipid. The dietary dioxin intake was also
found to be 41.1% lower in the 2011–2016 SEDOCCH
than the median 0.56 pg TEQ/kg body weight/day re-
ported in the 2002–2010 SEDOCCH (N = 625) [37], pro-
viding evidence that the blood dioxin and dietary dioxin
intake levels were decreasing nationally. The blood di-
oxin and dietary dioxin intake were also found to have
decreased in a similar way (approximately 41%), which
was in line with previous findings that documented sig-
nificant declines in dioxin levels in Japan [12]. A typical
dioxin congener, 2,3,7,8-tetrachlorodibenzo-para- dioxin
(TCDD), has a biological half-life of 6 to 11 years in
adults [38, 39], and all other congeners have similar
half-lives. In this study, 77.1% of the blood samples had
undetectable TCDD concentrations (Table 2). The
TCDD level found in this study is lower compared with
that in a previous study in Italy that has found a median
of 0.68 pg TEQ/g lipid [40]. Previous studies have identi-
fied diet as a major source of dioxin exposure [8, 35];
however, dioxin elimination can be influenced by several
factors such as body fat, which has been found to in-
crease/decrease blood dioxin levels and elimination rates
[38]. Since no significant differences were found in the
amount of body fat between the 2002–2010 SEDOCCH
(BMI ≈ 23 kg/m2) [20] and the 2011–2016 SEDOCCH
(BMI ≈ 23 kg/m2), it was surmised that the decrease in
dietary dioxin intake had contributed to the decline in
blood dioxins. Studies have shown that food dioxins
come mainly from atmospheric deposition [41]; there-
fore, the government’s efforts to reduce dioxin emissions
may have played a significant role in decreasing the di-
oxin levels in Japan.
Likewise, the upper blood dioxins range reported in
this study (56 pg TEQ/g lipid) fell well below the upper
range of 130 pg TEQ/g lipid [37] estimated in the 2002–
2010 SEDOCCH, providing additional evidence that the
blood dioxins in the Japanese population may be de-
creasing. Although other explanations might be possible,
one hypothesis was that this decreasing trend could have
been due to the decline of dioxins in the atmosphere be-
cause of the strict Japanese government’s laws that limit
incineration emissions. Even though it was found that
the blood dioxins and dietary dioxin intake were declin-
ing in the Japanese population sample, they should not
be interpreted as meaning that people now have a zero
risk of dioxin exposure [15].
In this study, 21.6% of the participants still had blood
dioxins ≥ 16 pg TEQ/g lipid, which was the median
blood dioxin TEQ reported in the 2002–2010
SEDOCCH [18, 37]. The higher blood dioxin levels re-
ported in the 2002–2010 SEDOCCH were found to be
linked to adverse health outcomes [2, 3, 8, 14–20].
Table 4 Relationship between log-transformed total blood dioxins (in pg TEQ/g lipid) and health parameters/clinical biomarkers,
2011–2016 SEDOCCH (N = 490)
Total TEQ with ‘zero’ substituted for dioxin
congeners < LOD
Total TEQ with dioxins imputed using
PMM
Total TEQ with dioxins imputed using
MICE
Predictor Coefficient (β) p value Adjusted R2 Coefficient (β) p value Adjusted R2 Coefficient (β) p value Adjusted R2
0.410 0.483 0.440
Age (years) 0.298 < 0.001 0.420 < 0.001 0.360 < 0.001
BMI (kg/m2) 0.164 < 0.001 0.112 0.003 0.136 0.001
DGLA (μg/mL) − 0.380 < 0.001 − 0.360 < 0.001 − 0.376 < 0.001
DHA (μg/mL) 0.362 < 0.001 0.315 < 0.001 0.321 < 0.001
Triglycerides (mg/dL) 0.158 0.002 0.134 0.002 0.131 0.003
Blood glucose (mg/dL) 0.057 0.142 0.098 0.008 0.087 0.024
ALT (IU/L) 0.067 0.090 0.048 0.215 0.080 0.050
Variables included in the model: age, BMI, triglycerides, blood glucose, blood urea nitrogen, ALT, DGLA, DHA, and sex
BMI, triglycerides, blood glucose, blood urea nitrogen, ALT, DGLA, and DHA were log-transformed
SEDOCCH survey on the exposure to dioxins and other chemical compounds in humans, PMM predictive mean matching, MICE multivariate imputation by chained
equations, BMI body mass index, ALT alanine aminotransferase, DGLA dihomo-gamma-linolenic acid, DHA docosahexaenoic acid, LOD limit of detection
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Therefore, the blood dioxins of ≥ 16 pg TEQ/g lipid
found in this study warrant further investigation because
of the potential long-term health effects. These results
also have implications for the MOEJ and highlighted the
critical need for longitudinal monitoring to assess
long-term public exposure to dioxins and to reduce
background exposure in the general population.
Relationship between blood dioxins and health
parameters/clinical biomarkers
The correlations reported in the 2002–2010 SEDOCCH
between blood dioxins and health parameters [2] were
also found in this study (2011–2016 SEDOCCH) for data
based both on non-detects equal to zero and the im-
puted data (Table 3). In particular, participants with
higher blood dioxin levels were more likely to have
higher BMIs, more elevated triglycerides, higher DHA
and EPA, and lower DGLA (Table 4) and then could be
explained by age, but not by smoking status. The associ-
ations between age and blood dioxins found in the
present study were expected, as chlorinated dioxins are
known to be generally more resistant to biotransform-
ation and elimination from the body. It was assumed
that the total body blood dioxins burden in this group
was probably due to the cumulative lifetime exposure to
dioxins rather than because of recent exposures, as the
dioxins half-life in the human body can exceed 7 years.
Therefore, the results might have reflected the dioxins
the participant had accumulated over a long time and a
slower dioxin elimination [42].
Our findings that biomarkers of fish intake, DHA and
EPA were associated with blood dioxins are in line with
the view of marine fish intake as one of the foods that
influence blood dioxins in Japan [14]. They support the
hypothesis that a significant portion of blood total TEQ
in Japan is from fish intake. The association between
blood dioxins and fish had been reported in the existing
literature [43–45]. Yet a study conducted in Russia could
not find associations between fish intake and blood di-
oxins in the overall participants though some partici-
pants who consumed high quantities of fish showed
higher serum dioxin levels [31]. While smoking status
has been found to be a predictor of blood dioxins [38,
41, 46], the findings that smoking status was not a sig-
nificant predictor was unexpected. Blood dioxin levels
were similar between never smokers and current
smokers. The relatively small number (21%, 102/490) of
current smokers and their relatively low mean age (com-
pared with never smokers) in this study could be the
most direct explanation for these unexpected findings.
Alternatively, this lack of association between blood di-
oxins and smoking could mean that the dioxin levels
were low in tobacco smoked by these participants.
However, the associations previously reported in Japan
between blood dioxins and dietary dioxin intake [15, 16]
were not found in the complete case analyses (i.e. when
the models were restricted to the 90 participants for
whom dietary dioxin intake estimations were available).
The non-detection of most congeners with high TEF
such as TCDD and tetrachlorodibenzofuran (TCDF) in
blood samples along with the non-representativeness of
the study population in the participant sub-sample and
the relatively small sample size after the list wise dele-
tion (n = 60 and n = 30 for high and low dioxin level
areas, respectively) could possibly explain these lack of
associations (Additional file 1: Table S2). In contrast,
when dietary dioxin intake was removed from the
models, with or without the imputed dioxin data, associ-
ations were found between blood dioxins and some
health parameters/clinical biomarkers (Table 4). The re-
sults of multiple regression analysis for associations be-
tween blood dioxin levels and food dioxin intake showed
that the effect of diet was small. One possible interpret-
ation of the null relationship is these participants’ overall
low exposure. To investigate the accurate kinetics, it is
necessary that research combines the exposure and the
pharmacokinetics models. In the present study, the
mean dioxin dietary intake level was found to be within
tolerable daily intake levels and was not found to be as-
sociated with blood dioxins after adjusting for potential
confounders. Although higher dioxin levels have been
reported in the Japanese, in addition to dioxin resistance
to degradation, this finding suggested that there was a
low accumulation of dioxins in the food consumed by
the study sample. It was concluded that these results
reflected the efforts made by the Japanese government
to reduce environmental dioxins through initiatives such
as proper waste incineration and the cleaning of
dioxin-contaminated soil [12]. It is also possible that the
dioxin intake in this study was underestimated as they
were only estimated in 90 participants from food sam-
ples that were collected for only 3 days. Nevertheless,
DHA and EPA were used to account for the foods that
may influence blood dioxins among the Japanese. These
findings add to the literature about the appropriate
handling of missing data in epidemiological investiga-
tions [47–49]. The simple substitution of the dioxin con-
gener values below the LOD is likely to generate biased
results (Table 4) because the simple substitution
methods caused an absence of any associations between
the blood dioxins and the blood glucose. Therefore, the
use of MICE and PMM to account for the missing data
among the dioxin congeners was able to yield adequate
results and reduce the possibility of making erroneous
conclusions. Although MICE and PMM are based on
different algorithms, in this study, they appeared to be
similar regarding robustness.
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Limitations of the study
Although this study considered all necessary factors,
there were some potential limitations. First, there was
possibly some bias in the participants’ enrolment; specif-
ically, participation was voluntary, and therefore, the
participants were not randomly enrolled. The 2011 to
2016 sampling was primarily concentrated in areas
where dioxin levels had been found to be high or low in
the 2002–2010 SEDOCCH survey [16]. Therefore, the
selection of the participants in the 2011–2016 SEDO
CCH may not have been truly represented the Japanese
population. Therefore, the 2011–2016 SEDOCCH sam-
ple size may not have been large enough to truly repre-
sent the Japanese population. However, this limitation
was mitigated by recruitment in all five Japanese regions
and the target number of participants recruited each
year. SEDOCCH investigators are now working to im-
prove the next SEDOCCH to ensure a true representa-
tiveness of the Japanese population. Second, although
the data on the individuals invited to participate in the
study and the response rates were not available, the
study succeeded in recruiting the planned number of
participants for the study design. Even though the inter-
views were conducted face-to-face, the absence of a bias
influence on the quality of responses obtained cannot be
ruled out [50]. Third, the cross-sectional design of the
study limited the interpretation of the findings, espe-
cially when the half-life of dioxins is known to exceed 7
years [4]. As most participants were only sampled once,
it was difficult to estimate the dioxin levels over time
along with the rates of decay. Previous studies have re-
ported that dioxin elimination can occur faster for
people with higher dioxin levels [42]. In this study,
63.5% of the participants had been recruited in areas
where the dioxin levels were reported as high (median
21.5 to 40.9 pg TEQ/g lipid) in the 2002–2010 SEDO
CCH results; therefore, it could be speculated that the
participant group may have experienced faster dioxin
elimination. This observation and the low dioxin intake
might be the reason for the dramatic decline in dioxins,
even though dioxins tend to have longer half-lives. The
oversampling of participants from prefectures in which
the blood dioxin levels had been found to be high in the
2002–2010 SEDOCCH surveys contributed to enabling
the evaluation of the government action to reduce
dioxins in Japan. In these areas, the median blood
dioxins were 10 pg TEQ/g lipid in the 2011–2016
SEDOCCH surveys.
Fourth, comparing our dietary dioxin intake measure-
ments to the values reported in the 2002–2010
SEDOCCH surveys may also have introduced some bias.
This is for reasons that the 2002–2010 SEDOCCH diet-
ary data are more than 10 years old and were carried out
in participants who were likely to live in urban areas (vs.
rural areas in this study). However, the 2002–2010
SEDOCCH dietary dioxin intake estimations were from
nationwide surveys and were set as a reference by the
MOEJ for this report.
Despite these limitations, this study contributes to
studies on dioxin levels. First, the findings provide in-
sights into planning future epidemiological research to
address dioxin-related issues and assists in public-pol-
icy decisions. Second, missing data is uncommon; for
example, the questionnaire answers only had a little
missing data because individual interviews were carried to
accompany the previously completed self-administered
questionnaire.
Conclusions
Median blood dioxins and dietary dioxin intake were
found to be approximately 41% lower in this study com-
pared with those in the 2002–2010 SEDOCCH. It was
found that the measures and actions undertaken in
Japan have possibly contributed to these reductions in
the body burden of dioxins in the Japanese population.
In our non-occupationally exposed Japanese population,
blood dioxins were found to be associated with clinical
biomarkers including DHA and EPA. As fish intake may
benefit health in humans, we recommend additional
government actions to further reduce potential dioxin
contaminants in fish.
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